Related Experiment Video
Updated: May 17, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With
Carolyn Y Fang1, Alexander W MacFarlane1, Henry C H Fung1
1Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.
None:
Asymptomatic patients with a new diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) are commonly managed by active surveillance as per International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria; however, many patients report elevated distress during surveillance. Psychological distress may have biologic implications given that natural killer [NK] cells, T cells, and monocytes are not only sensitive to distress, but also critical in controlling disease progression. Therefore, the objective of this study was to explore associations of distress with immune biomarkers in patients with CLL/SLL being managed by active surveillance. We enrolled 76 participants and assessed perceived stress, anxiety, and depressive symptoms at study entry and every 6 months for up to 2 years during active surveillance. Blood samples were collected at the same time points to assess biomarkers on T cell, NK cell, and monocyte subsets. In multivariable regression analyses, higher levels of perceived stress and anxiety were significantly associated with lower percentages of intermediate monocytes (IM); anxiety was also significantly associated with higher percentages of classical monocytes (CM). In longitudinal analyses, higher stress and anxiety were significantly associated with higher percentages of CM at 12 months. This is one of the first studies to observe that psychological distress is associated with differential patterns of monocyte distribution in patients with CLL/SLL managed with active surveillance.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012